Boule Diagnostics

22/04/2026

Today we reflect on our shared responsibility to protect our planet.
Together with our partners, we work toward more sustainable practices in diagnostics and healthcare.
Thank you for contributing to a healthier world!

15/04/2026

When treating canine lymphoma, survival isn’t the only measure that matters.
Quality of life during chemotherapy is just as important, for both veterinarians and pet owners.
Research featured in our article shows that dogs undergoing treatment can experience improvements in energy, appetite, and willingness to play, alongside measurable changes in blood parameters.
Insights like these can help support more informed decisions in veterinary oncology.

Read the full article:

Researchers in Macedonia have evaluated the quality of life in dogs with lymphoma before, during, and after chemotherapy.

07/04/2026

On World's Health Day, we recognize the vital role healthcare professionals play in improving lives.
Your dedication shapes stronger, more resilient health systems across the world.
Thank you for the impact you create every day.

Curious to learn more about how Boule supports this mission through advancing hematology diagnostics?
Check our portfolio here: https://boule.com/diagnostics-systems/

02/04/2026

Happy Easter to everyone celebrating.
We're particularly thankful to our partners, whose continuous support empowers us to serve labs and healthcare professionals every day.
Thank you for being part of our journey.

22/12/2025

Warm holiday wishes to all our partners!
Your collaboration and commitment make a difference for labs and healthcare professionals worldwide.
Thank you for being part of the Boule Diagnostics community.

14/11/2025

Today marks an important milestone in Boule’s ongoing evolution. AllBright’s 2025 review highlights us as one of Sweden’s most gender-equal listed companies, with our leadership team reaching a 50/50 balance. This recognition reflects more than numbers: it speaks to how we work and who we strive to be.
For over 60 years, Boule has grown through innovation, scientific integrity, and a deep belief in responsibility. As we advance our brand identity and continue modernizing how we operate, equality remains a core part of that journey. A balanced leadership team strengthens our decisions, our culture, and the impact we make in diagnostics worldwide.
We're proud of the progress so far and committed to going further.

22/10/2025

New look, same trusted performance.

Boule is refreshing the visual identity of its hematology analyzers to strengthen our position as a trusted diagnostics partner. Our analyzers will gradually adopt a unified Boule design, distinguished by color-coded fronts for each product line.*

🔸 No technical changes – performance and reliability remain the same.

🔸 Transition period – both current and new designs may be delivered for the rest of Q4.

🔸 Training materials – may still show the previous design for a period.

🔸 Easy access to product documents – each device now includes a QR code linking to a sustainable digital format, making it easier to find manuals and user information anytime.

These new fronts mark the next step in Boule’s journey toward a modern, unified diagnostics portfolio. Check out a sneak peek in the video to see some of the refreshed models!

* ‎This change impacts the BM850 platform, which includes: Medonic M32, Swelab Alfa Plus, Exigo H400. Please allow a transition time for a complete deployment in your region.

16/10/2025

We’re excited to unveil Boule’s refreshed brand identity, a modern evolution that reflects our ambition and commitment to being the trusted partner in diagnostics worldwide.

Our new logo builds on Boule’s rich heritage to lay the foundation for a brighter, future-focused story across every touchpoint.

This is more than a design change, it’s a new chapter in Boule’s journey.

👉 You’ll notice changes gradually across our channels. Stay tuned as we make this transition.

17/01/2025

We we will be exhibiting at Medlab Middle East 2025!
If you're attending Medlab, we warmly invite you to visit our booth. Let's connect and share insights within the field of hematology. Discover our solutions and see how we can support your laboratory's needs. Our team is looking forward to engaging with you and exploring opportunities for collaboration. See you there! 👋

📅 Date: February 3- February 6, 2025 📍 Location: Dubai World Trade Centre 🏢 Booth Number: Z4.C29

10/01/2025

An incentive for centralization of diagnostic testing is the possibility to improve testing efficiency, while lowering the cost per test. However, there are situations where near-patient testing can be of greater benefit to the patient. Not only is on-site testing convenient for the patient, omitting the need to travel a longer distance to a site for blood sampling and testing. On-site testing can also be crucial for reducing turnaround time in case quick response is required to meet urgent clinical needs. Learn more in this white paper; https://boule.com/bouleacademy/literature/white-paper-measurement-quality/ #

30/12/2024

Study on rock bream iridovirus (RBIV) infection reveals similarities and differences between infection routes in rock bream. Read more at; https://boule.com/news/rock-bream-iridovirus-rbiv-infection/

Rock bream is an important species for fish farming. Outbreaks of the rock bream iridovirus RBIV constitute a health risk to the aquacultures

23/12/2024

🎄 Season's Greetings and Best Wishes for 2025 from Boule!
Thank you for your trust and support this year – we truly value our partnership. Let´s continue Improving health for everyone, everywhere!

Happy Holidays and a Happy New Year! 🌟